 |
 |
Hi murray, Thanks for the info. I live quite far from them so I think fax or phone would be too expensive. I was thinking of writing instead. I might look up their postal address on the web and then I'll let everyone know when I get a reply. It would be handy to get an email address also but I looked up their site and couldn't find one. Thanks again, Sinead > ---------- > From: Murray Charters[SMTP:[log in to unmask]] > Reply To: Parkinson's Information Exchange Network > Sent: Wednesday, May 03, 2000 1:35 PM > To: [log in to unmask] > Subject: GPI-1046 & Amgen Was: GPI-1-46 Research > > On 3 May 2000, at 10:06, Sinead Aungier wrote: > > > Does anyone know where on the web I can find out what the current status > is > > on the research for GPI-1-46? > > > > Sinead > > Hi Sinead, > > BACKGROUND.... > GUILFORD ACHIEVES DEVELOPMENT MILESTONE > IN NEUROIMMUNOPHILIN PARTNERSHIP WITH AMGEN > Monday 28 September 1998 > http://www.prnewswire.co.uk/prn-cgi/release?26478 > > Guilford Pharmaceuticals Products > http://www.guilfordpharm.com/fs_products_nf.htm > > For updated information, please contact > Amgen Professional Services at 1-800-772-6436 or by fax 805-376-8550. > > Dial up or Send them a fax and give us the results... > > All the best ....... murray > > [log in to unmask] >